Browse by Journal Title

Article

The CAIRP (CAndesartan for In-stent Restenosis Prevention) trial - A multicenter study of AT1-receptor blocker therapy in coronary stenting.
Kraemer, J. and Ruf, R.G. and Schmidt, S. and Axthelm, C. and Strasser, R. and Janssen, G. and Thieme, T. and Kusch, A. and Waigand, J. and Dietz, R. and Gross, C.M.
Journal of Invasive Cardiology 20 (5): 205-210. May 2008

Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
Gross, C.M. and Perrot, A. and Geier, C. and Posch, M.G. and Hassfeld, S. and Kramer, J. and Schmidt, S. and Derer, W. and Dietz, R. and Oezcelik, C.
Journal of Invasive Cardiology 19 (6): 261-264. 1 June 2007